Flower Antigens
NDC 44911-0324, Arsenicum Album, Lycopodium Clavatum, Pulsatilla (Pratensis), Bellis Perennis, Calendula Officinalis, Camellia Japonica, Chrysanthemum Coronarium, Chrysanthemum Leucanthemum, Convallaria Majalis, Gardenia Jasminoides, Impatiens Glandulifera, Flos, Iris Tenax, Lilium Tigrinum, Narcissus Pseudo-Narcissus, Rosa Damascena, Syringa Vulgaris, liquid, from Energique, Inc..
- Product NDC
- 44911-0324
- Status
- Listed
- Labeler
- Energique, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0324 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ARSENIC TRIOXIDE12 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE12 [hp_X]/mL
- PULSATILLA PRATENSIS WHOLE12 [hp_X]/mL
- BELLIS PERENNIS WHOLE12 [hp_C]/mL
- CALENDULA OFFICINALIS FLOWERING TOP12 [hp_C]/mL
- CAMELLIA JAPONICA FLOWER12 [hp_C]/mL
- GLEBIONIS CORONARIA WHOLE12 [hp_C]/mL
- LEUCANTHEMUM VULGARE WHOLE12 [hp_C]/mL
- CONVALLARIA MAJALIS12 [hp_C]/mL
- GARDENIA JASMINOIDES FLOWER12 [hp_C]/mL
- IMPATIENS GLANDULIFERA FLOWER12 [hp_C]/mL
- IRIS TENAX WHOLE12 [hp_C]/mL
- LILIUM LANCIFOLIUM WHOLE FLOWERING12 [hp_C]/mL
- NARCISSUS PSEUDONARCISSUS FLOWER12 [hp_C]/mL
- ROSA DAMASCENA FLOWERING TOP12 [hp_C]/mL
- SYRINGA VULGARIS FLOWER12 [hp_C]/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44911-0324-1 | 44911032401 | 30 mL in 1 BOTTLE, DROPPER (44911-0324-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 44911-0324 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0324 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44911-0324. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.